HI TECH PHARMACAL CO INC·4

Nov 14, 4:19 PM ET

SELTZER DAVID S 4

4 · HI TECH PHARMACAL CO INC · Filed Nov 14, 2011

Insider Transaction Report

Form 4
Period: 2011-11-10
SELTZER DAVID S
DirectorCEO, President, Sec'y, Treas.10% Owner
Transactions
  • Exercise/Conversion

    Common Stock

    2011-11-10$3.84/sh+112,500$432,0001,286,620 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2011-11-10112,5000 total
    Exercise: $3.84From: 2002-11-15Exp: 2011-11-15Common Stock (112,500 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    222,902
Footnotes (3)
  • [F1]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan
  • [F2]The option became exercisable in four (4) equal installments beginning on the first anniversary of the grant date.
  • [F3]Other than the option reflected on this form, Mr. Seltzer is also the holder of additional options to acquire an aggregate of 562,500 additional shares of Hi-Tech Common Stock, which options were granted on various dates, with various exercise prices, exercise dates and expiration dates.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT